Get my own profile
Public access
View all41 articles
9 articles
available
not available
Based on funding mandates
Co-authors
- Andrew EwingUniversity of Gothenburg, NanoSIMS-Chemical Imaging Infrastructure CIIVerified email at chem.gu.se
- John S FletcherUniversity of GothenburgVerified email at gu.se
- Peter SjövallResearch Scientist, RISE Research Institutes of SwedenVerified email at ri.se
- Ibrahim KayaDepartment of Pharmaceutical Biosciences, Uppsala UniversityVerified email at farmbio.uu.se
- Lin RenChalmers University of TechnologyVerified email at chalmers.se
- Lina Hagvallass. prof. University of GothenburgVerified email at gu.se
- Jelena LovricAstraZenecaVerified email at astrazeneca.com
- Johan DunevallSystem Engineer at Gyros Protein TechnologiesVerified email at gyrosproteintech.com
- Michael E. KurczyAstraZeneca, NanoSIMS - Chemical Imaging Infrastructure CIIVerified email at astrazeneca.com
- Aurélien ThomenCAMECA - AMETEKVerified email at ametek.com
- Itai PanasProfessor of Theoretical ChemistryVerified email at chalmers.se
- Jerker MårtenssonChalmers University of TechnologyVerified email at chalmers.se
- Jörg HanriederUniversity of Gothenburg, University College LondonVerified email at neuro.gu.se
- Shalini AnderssonChief Scientist & Head of Oligonucleotide discovery, AstraZenecaVerified email at astrazeneca.com
- Soodabeh MajdiUniversity of GothenburgVerified email at chem.gu.se
- Lars-Gunnar JohanssonProfessor of Inorganic Chemistry, Chalmers University of TechnologyVerified email at chalmers.se
- Nhu TN PhanUniversity of GothenburgVerified email at chem.gu.se
- Tina B. AngererChemist, Swedish Food AgencyVerified email at slv.se
- Anna LarssonUniversity of GothenburgVerified email at chem.gu.se
- Marica EricsonBiomedical photonics, University of GothenburgVerified email at chem.gu.se
Follow
Per Malmberg
Chalmers University of Technology, Chemical Imaging infrastructure CII
Verified email at chalmers.se - Homepage